Evaluation of the Efficacy and Safety of DA-9601 versus Its New Formulation, DA-5204, in Patients with Gastritis: Phase III, Randomized, Double-Blind, Non-Inferiority Study

This study compared the efficacy of DA-9601 (Dong-A ST Co., Seoul, Korea) and its new formulation, DA-5204 (Dong-A ST Co.), for treating erosive gastritis. This phase III, randomized, multicenter, double-blind, non-inferiority trial randomly assigned 434 patients with endoscopically proven gastric m...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yoon Jin, Lee, Dong Ho, Choi, Myung-Gyu, Lee, Sung Joon, Kim, Sung Kook, Song, Geun Am, Rhee, Poong-Lyul, Jung, Hwoon-Yong, Kang, Dae-Hwan, Lee, Yong Chan, Lee, Si Hyung, Choi, Suck Chei, Shim, Ki-Nam, Seol, Sang-Yong, Moon, Jeong Seop, Shin, Yong Woon, Kim, Hyun-Soo, Lee, Soo Teik, Cho, Jin Woong, Choi, Eun Kwang, Lee, Oh Young, Jang, Jin Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639061/
https://www.ncbi.nlm.nih.gov/pubmed/28960033
http://dx.doi.org/10.3346/jkms.2017.32.11.1807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639061/
https://www.ncbi.nlm.nih.gov/pubmed/28960033
http://dx.doi.org/10.3346/jkms.2017.32.11.1807

Ejemplares similares